UT Health San Antonio

Robert A Hromas, MD, FACP

Dean, Joe R. and Teresa Lozano Long School of Medicine

Dr. Hromas is the Dean at the Long School of Medicine at the University of Texas Health Science Center at San Antonio (UT Health San Antonio). The Long School of Medicine has 1700 faculty, 960 medical students, 970 residents and fellows, and cares for over 2.8 million patients annually. Prior to that, he was Chair of the Department of Medicine at the University of Florida, where he was also Vice President of the University of Florida Physicians Clinical Practice Association, and a member of the University of Florida Health Hospital Executive Board. He has personally trained 29 graduate students or fellows, most of which have entered academic careers, and 21 junior faculty, almost all of which have obtained tenure, with three obtaining Hematology-Oncology Division Chief Positions and two Chairs of Medicine. He has served on editorial boards of Blood and Stem Cells. He has won numerous teaching and patient care awards, including the Indiana University Humanism in Medical Education Award, the Indiana University Board of Trustees Outstanding Teacher Award, and the People Living Through Cancer Caring Award. He has served as Chair of Scientific Affairs for the American Society of Hematology, and as one of their congressional and media representatives. He has served as a full member of the Liaison Committee on Medical Education, the nation’s medical school accrediting body. He has published over 200 research papers, been continuously funded by the National Institutes of Health for over three decades and has chaired multiple NIH and American Cancer Society study sections. He has multiple patents and has co-founded two biotechnology companies, Abfero and Dialectic Therapeutics, both with compounds in phase 2 clinical trials. His laboratory has isolated and characterized multiple novel cytokines and several DNA mutations leading to leukemia. He has also identified several key components of DNA repair pathways that can be targeted in BRCA-deficient cancers. He is the author of the Harper-Collins business leadership book, Einstein’s Boss- 10 Rules for Leading Genius. For these and other accomplishments he has been elected to the American Society of Clinical Investigation, Association of Professors of Medicine, the American Clinical and Climatologic Association, and the Association of American Physicians.